Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: A 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 7, 2003, Pages 389-400

  Cardascia, Nicola ^a   Vetrugno, Michele ^a   Trabucco, Tiziana ^a   Cantatore, Francesco ^a   Sborgia, Carlo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Intraocular pressure; Latanoprost; Primary open angle glaucoma; Pulsatile ocular blood flow; Travoprost

Indexed keywords

EYE DROPS; LATANOPROST; PROSTAGLANDIN DERIVATIVE; TRAVOPROST;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD RHEOLOGY; BODY MASS; BRACHIAL ARTERY; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVA DISEASE; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SELF ADMINISTRATION; EYE BLOOD FLOW; FEMALE; HEART RATE; HEMODYNAMICS; HUMAN; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OPTIC NERVE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY DYSFUNCTION; SHORT COURSE THERAPY; SIDE EFFECT;

EID: 0141506063     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(03)00112-7     Document Type: Article

References (29)

1. Kuba GB, Kurnatowski-Billion M, Neuser AM, Austermann P. Effect of latanoprost on ocular hemodynamics and contrast sensitivity [in German]. Ophthalmologe. 2001;98:535-540.
2. Geyer O, Man O, Weintraub M, Silver DM. Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes. Am J Ophthalmol. 2001;131:198-202.
3. Tamaki Y, Nagahara M, Araie M, et al. Topical latanoprost and optic nerve head and retinal circulation in humans. J Ocul Pharmacol Ther. 2001;17:403-411.
4. Ishii K, Tomidokoro A, Nagahara M, et al. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans. Invest Ophthalmol Vis Sci. 2001;42:2957-2963.
5. Stjernschantz J, Selen G, Astin M, Resul B. Microvascular effects of selective prostaglandin analogues in eye with special reference to latanoprost and glaucoma treatment. Prog Retin Eye Res. 2000;19:459-496.
6. Vetrugno M, Cantatore F, Gigante G, Cardia L. Latanoprost 0.005% in POAG: Effects on IOP and ocular blood flow. Acta Ophthalmol Scand Suppl. 1998;40-41.
7. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye. 1999;13:31-34.
8. Georgopoulos GT, Diestelhorst M, Fisher R, et al. The short-term effect of latanoprost on intraocular pressure and pulsatile ocular blood flow. Acta Ophthalmol Scand. 2002;80:54-58.
9. Hellberg MR, Sallee VL, McLaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocul Pharmacol Ther. 2001;17:421-432.
10. Whitson JT. Travoprost - a new prostaglandin analogue for the treatment of glaucoma. Expert Opin Pharmacother. 2002;3:965-977.
11. Fellman RL, Sullivan EK, Ratliff M, et al. Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: A 6-month, masked, multicenter trial. Ophthalmology. 2002;109:998-1008.
12. Sponsel WE, Ritch R, Stamper R, et al. Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol. 1995;120:699-708.
13. Langham ME, Farrel LA, O'Brien V, et al. Blood flow in the human eye. Acta Ophthalmol. 1989;191:9-12.
14. Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472-484.
15. Aung T, Chew PT, Yip CC, et al. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 2001;131:636-642.
16. Yoles E, Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol. 1998;42:367-372.
17. Flammer J, Gasser P, Prunte CH. The probable involvement of factors other than intraocular pressure in the pathogenesis of glaucoma. In: Drance SM, Van Buskirk EM, Neufeld AH, eds. Pharmacology of Glaucoma. Baltimore, Md: Williams & Wilkins; 1992:273-283.
18. Hayreh SS. Optic nerve head and blood supply in health and disease. In: Lambrou GN, Greve EL, eds. Ocular Blood Flow in Glaucoma: Means, Methods and Measurements. Proceedings of the Meeting of the European Glaucoma Society, September 9-10, 1988, Paris, France. Amsterdam, the Netherlands: Kugier & Ghedini; 1989:3-49.
19. Bill A, Sperber GO. Control of retinal and choroidal blood flow. Eye. 1990;4:319-325.
20. Büchi ER. The blood supply to the optic nerve head. In: Kaiser HJ, Flammer J, Hendrickson P, eds. Ocular Blood Flow: New Insights into the Pathogenesis of Ocular Diseases. Glaucoma Meeting, March 24-25, 1995, Basel, Switzerland. Basel: Karger; 1996:1-8.
21. Pillunat L, Stodtmeister R. Effect of different antiglaucomatous drugs on ocular perfusion pressures. J Ocul Pharmacol. 1988;4:231-242.
22. Langham ME. The influence of timolol, clonidine and aminoclonidine on ocular blood flow in the rabbit and human subjects. Invest Ophthalmol Vis Sci. 1990;31:378.
23. Trew DR, Smith SE. Postural studies in pulsatile ocular blood flow: II. Chronic open angle glaucoma. Br J Ophthalmol. 1991;75:71-75.
24. Simmons ST, Earl ML. Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: Tolerance and peak intraocular pressure lowering. Ophthalmology. 2002;109:307-315.
25. Orengo-Nania S, Landry T, Von Tress M, et al. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am J Ophthalmol. 2001;132:860-868.
26. Vetrugno M, Maino A, Cantatore F, et al. Acute and chronic effects of brimonidine 0.2% on intraocular pressure and pulsatile ocular blood flow in patients with primary open-angle glaucoma: An open-label, uncontrolled, prospective study. Clin Ther. 2001;23:1519-1528.
27. Schilder P. Ocular blood flow changes with increased vascular resistance external and internal to the eye. Acta Ophthalmol Suppl. 1989;191:19-23.
28. Hjortdal JO, Hjortdal VE, Hansen ES, et al. Effect of acute intraocular pressure reduction on regional ocular blood flow. Doc Ophthalmol. 1991;77:145.
29. Pillunat LE, Stodtmeister R, Wilmanns I, Christ T. Autoregulation of ocular blood flow during changes in intraocular pressure: Preliminary results. Graefes Arch Clin Exp Ophthalmol. 1985;223:219-223.